Menu
US
Application Note

Label-free analysis of cardiomyocyte beating using the Opera Phenix Plus System

app-482224-cardiomyocyte-beating-opera-phenix-plus512.jpg

Drug-induced cardiotoxicity is a frequent cause of drug attrition during drug development and can lead to the withdrawal of drugs from the market, so non-invasive approaches that allow quick and reliable assessment of the cardiotoxic potential of a compound are key to improve drug safety.

In this application note, learn how the Opera Phenix® Plus high-content screening system can be used for:

  • Reliable quantification of cardiomyocyte beating frequency
  • Fast frame rate imaging up to 100 fps to accurately capture fast cellular responses
  • Tip-based on-board pipetting compatible with 96 and 384-well plates
  • Stable environmental conditions with temperature, CO2, and humidity control

For research use only, not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Label-free analysis of cardiomyocyte beating using the Opera Phenix Plus System

Download Application Note